DYN logo

Dyne Therapeutics, Inc. (DYN) Depreciation and amortization

annual D&A:

$1.67M$0.00(0.00%)
December 31, 2024

Summary

  • As of today (August 20, 2025), DYN annual depreciation & amortization is $1.67 million, unchanged on December 31, 2024.
  • During the last 3 years, DYN annual D&A has risen by +$585.00 thousand (+53.77%).
  • DYN annual D&A is now -0.59% below its all-time high of $1.68 million, reached on December 31, 2022.

Performance

DYN Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNincome statement metrics

quarterly D&A:

$503.00K+$1000.00(+0.20%)
June 30, 2025

Summary

  • As of today (August 20, 2025), DYN quarterly depreciation & amortization is $503.00 thousand, with the most recent change of +$1000.00 (+0.20%) on June 30, 2025.
  • Over the past year, DYN quarterly D&A has increased by +$104.00 thousand (+26.07%).
  • DYN quarterly D&A is now -68.60% below its all-time high of $1.60 million, reached on June 30, 2022.

Performance

DYN quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNincome statement metrics

TTM D&A:

$2.46M+$104.00K(+4.41%)
June 30, 2025

Summary

  • As of today (August 20, 2025), DYN TTM depreciation & amortization is $2.46 million, with the most recent change of +$104.00 thousand (+4.41%) on June 30, 2025.
  • Over the past year, DYN TTM D&A has increased by +$514.00 thousand (+26.37%).
  • DYN TTM D&A is now -33.14% below its all-time high of $3.68 million, reached on June 30, 2022.

Performance

DYN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNincome statement metrics

DYN Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year0.0%+26.1%+26.4%
3 y3 years+53.8%-68.6%-33.1%
5 y5 years+517.3%+218.3%+1458.9%

DYN Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.6%+53.8%-68.6%+248.8%-33.1%+56.5%
5 y5-year-0.6%+517.3%-68.6%+248.8%-33.1%+1458.9%
alltimeall time-0.6%+6870.8%-68.6%+248.8%-33.1%+1458.9%

DYN Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$503.00K(+0.2%)
$2.46M(+4.4%)
Mar 2025
-
$502.00K(-50.8%)
$2.36M(+5.2%)
Dec 2024
$1.67M(0.0%)
$1.02M(+132.9%)
$2.24M(+25.3%)
Sep 2024
-
$438.00K(+9.8%)
$1.79M(-8.2%)
Jun 2024
-
$399.00K(+3.4%)
$1.95M(-12.4%)
Mar 2024
-
$386.00K(-31.9%)
$2.22M(-9.6%)
Dec 2023
$1.67M(-0.6%)
$567.00K(-5.0%)
$2.46M(-1.9%)
Sep 2023
-
$597.00K(-11.4%)
$2.51M(+59.4%)
Jun 2023
-
$674.00K(+8.2%)
$1.57M(-37.1%)
Mar 2023
-
$623.00K(+1.3%)
$2.50M(-25.2%)
Dec 2022
$1.68M
$615.00K(-282.0%)
$3.35M(+8.9%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$338.00K(-121.1%)
$3.07M(-16.6%)
Jun 2022
-
$1.60M(+9.3%)
$3.68M(+58.6%)
Mar 2022
-
$1.47M(+329.9%)
$2.32M(+113.5%)
Dec 2021
$1.09M(+55.4%)
$341.00K(+24.0%)
$1.09M(+12.9%)
Sep 2021
-
$275.00K(+14.1%)
$964.00K(+11.6%)
Jun 2021
-
$241.00K(+4.3%)
$864.00K(+10.6%)
Mar 2021
-
$231.00K(+6.5%)
$781.00K(+42.0%)
Dec 2020
$700.00K(+158.3%)
$217.00K(+24.0%)
$550.00K(+65.2%)
Sep 2020
-
$175.00K(+10.8%)
$333.00K(+110.8%)
Jun 2020
-
$158.00K
$158.00K
Dec 2019
$271.00K(+1029.2%)
-
-
Dec 2018
$24.00K
-
-

FAQ

  • What is Dyne Therapeutics, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. annual D&A year-on-year change?
  • What is Dyne Therapeutics, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. quarterly D&A year-on-year change?
  • What is Dyne Therapeutics, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. TTM D&A year-on-year change?

What is Dyne Therapeutics, Inc. annual depreciation & amortization?

The current annual D&A of DYN is $1.67M

What is the all time high annual D&A for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high annual depreciation & amortization is $1.68M

What is Dyne Therapeutics, Inc. annual D&A year-on-year change?

Over the past year, DYN annual depreciation & amortization has changed by $0.00 (0.00%)

What is Dyne Therapeutics, Inc. quarterly depreciation & amortization?

The current quarterly D&A of DYN is $503.00K

What is the all time high quarterly D&A for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high quarterly depreciation & amortization is $1.60M

What is Dyne Therapeutics, Inc. quarterly D&A year-on-year change?

Over the past year, DYN quarterly depreciation & amortization has changed by +$104.00K (+26.07%)

What is Dyne Therapeutics, Inc. TTM depreciation & amortization?

The current TTM D&A of DYN is $2.46M

What is the all time high TTM D&A for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high TTM depreciation & amortization is $3.68M

What is Dyne Therapeutics, Inc. TTM D&A year-on-year change?

Over the past year, DYN TTM depreciation & amortization has changed by +$514.00K (+26.37%)
On this page